Turner Investments’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-109,436
| Closed | -$946K | – | 297 |
|
|
2016
Q4 | $946K | Sell |
109,436
-67,770
| -38% | -$586K | 0.38% | 98 |
|
|
2016
Q3 | $1.12M | Buy |
177,206
+50,080
| +39% | +$317K | 0.37% | 93 |
|
|
2016
Q2 | $536K | Sell |
127,126
-109,730
| -46% | -$463K | 0.17% | 137 |
|
|
2016
Q1 | $1.03M | Sell |
236,856
-15,929
| -6% | -$69.5K | 0.28% | 111 |
|
|
2015
Q4 | $1.55M | Hold |
252,785
| – | – | 0.32% | 92 |
|
|
2015
Q3 | $1.45M | Hold |
252,785
| – | – | 0.29% | 107 |
|
|
2015
Q2 | $1.89M | Sell |
252,785
-100,355
| -28% | -$749K | 0.35% | 97 |
|
|
2015
Q1 | $2.11M | Buy |
353,140
+229,430
| +185% | +$1.37M | 0.38% | 91 |
|
|
2014
Q4 | $935K | Sell |
123,710
-70,520
| -36% | -$533K | 0.11% | 280 |
|
|
2014
Q3 | $1.01M | Buy |
+194,230
| New | +$1.01M | 0.06% | 351 |
|